Table 2

Medical treatment after index event at interview: EUROASPIRE III

MenWomenp Value*
Secondary prevention treatment
 Aspirin or antiplatelets91.288.30.03
 β Blockers79.480.80.51
 Statins78.975.70.39
 ACE60.259.20.01
 Angiotensin II receptor antagonist10.915.3<0.0001
Cardiovascular risk factor treatment
 Anticoagulants5.75.40.07
 Calcium antagonists22.330.7<0.0001
 Nitrates26.034.5<0.0001
 Diuretics26.441.3<0.0001
 Insulin5.58.8<0.0001
 Oral antidiabetic agent13.617.00.0003
  • Results are shown as percentages.

  • * Significance between sexes adjusted for age and centre.